Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
2.
Clin Neurol Neurosurg ; 193: 105794, 2020 06.
Article in English | MEDLINE | ID: mdl-32203707

ABSTRACT

OBJECTIVE: Depression, anxiety, and obsessive-compulsive disorder have been widely reported in patients with dystonia. On the other hand, cognitive impairment, frontal lobe function, impulsiveness and pseudobulbar affect are less studied. The objective of the study is to assess these neuropsychiatric symptoms along with the quality of life of subjects with craniocervical dystonia. PATIENTS AND METHODS: A cross-sectional study was carried out in patients with craniocervical dystonia. Sex- and age-matched healthy controls were included. Neuropsychiatric assessment included the Montreal Cognitive Assessment (MoCA), Frontal Assessment Battery (FAB), Barrat Impulsiveness Scale (BIS-11), Center for Neurologic Study-Lability Scale (CNS-LS), Anxiety Rating Scale (HAM-A), Hamilton Depression Rating Scale (HAM-D), and the 12-item Short Form Health Survey (SF-12). RESULTS: A total of 44 patients with craniocervical dystonia and 44 controls were included. The mean age was 57 ± 13.7 years. Depression (56.1 % vs 9.1 %, p < 0.001), anxiety (56.8 % vs 6.8 %, p < 0.001), and pseudobulbar affect (31.8 % vs 9.1 %, p = 0.02) were more common in the dystonia group in comparison to controls. No difference between groups was found in impulsiveness (p = 0.65), MoCA score (p = 0.14) or executive dysfunction (p = 0.42). Quality of life was worst in the dystonia group with 90.9 % (p = 0.03) and 61.4 % (p < 0.001) of the subjects scoring under average in the Physical Composite Score (PCS) and Mental Composite Score (MCS) of the SF-12. CONCLUSION: MoCA scores ≤18, pseudobulbar affect, depression and anxiety are more prevalent in subjects with craniocervical dystonia in comparison to sex- and age-matched healthy controls. Regarding quality of life, MCS is more affected that the PCS in subjects with dystonia.


Subject(s)
Torticollis/psychology , Adult , Aged , Anxiety/psychology , Case-Control Studies , Cognitive Dysfunction/etiology , Cognitive Dysfunction/psychology , Cross-Sectional Studies , Depression/psychology , Executive Function , Female , Humans , Impulsive Behavior , Male , Mental Status and Dementia Tests , Middle Aged , Neuropsychological Tests , Pseudobulbar Palsy/psychology , Quality of Life
3.
Acta neurol. colomb ; 35(supl.1): 63-68, set. 2019.
Article in Spanish | LILACS | ID: biblio-1019314

ABSTRACT

RESUMEN Las alteraciones del sueño y el dolor, síntomas que han venido siendo cada vez más reconocidos como síntomas no motores en la enfermedad de Parkinson, pueden ser tan incapacitantes como los síntomas motores e impactan significativamente la calidad de vida de quienes los padecen. En este artículo se habla de la importancia del reconocimiento, el abordaje y el tratamiento de los trastornos del sueño más frecuentes en pacientes como Parkinson, como el trastorno conductual del sueño MOR, el insomnio y sueño fragmentado, la somnolencia diurna y el síndrome de piernas inquietas, así como el abordaje general del dolor en el paciente con esta enfermedad.


SUMMARY Sleep disorders and pain are symptoms that have been increasingly recognized as non-motor symptoms in Parkinson's disease, these no motor symptoms can be some of the most disabling and significantly impact the quality of life of patients that suffer it. This article discusses the importance of the recognition, approach and treatment of the most frequent sleep disorders in patients with Parkinson's disease, such as MOR sleep behavior disorder, insomnia and fragmented sleep, daytime sleepiness and restless legs syndrome, as well as the general approach to pain in patients with this disease.


Subject(s)
Transit-Oriented Development
4.
Arq Neuropsiquiatr ; 76(8): 517-521, 2018 08.
Article in English | MEDLINE | ID: mdl-30231124

ABSTRACT

OBJECTIVES: The wearing-off phenomenon is common in patients with Parkinson's disease. Motor and non-motor symptoms can fluctuate in relation to the "on/off" periods. To assess the impact of motor and non-motor wearing-off on activities of daily living and quality of life of patients with PD. METHODS: A cross-sectional study was carried out. All patients were evaluated using the Movement Disorders Society Unified Parkinson's Disease Rating Scale. Wearing-off was assessed using the Wearing-Off Questionnaire-19, and quality of life was assessed using the Parkinson's Disease Questionnaire-8. RESULTS: A total of 271 patients were included; 73.4% had wearing-off; 46.8% had both motor and non-motor fluctuations. Patients with both motor and non-motor wearing-off had a worst quality of life compared with those with only motor fluctuations (p = 0.047). CONCLUSIONS: Motor and non-motor fluctuations have an impact on activities of daily living and quality of life. Non-motor wearing-off may have a higher impact.


Subject(s)
Activities of Daily Living , Motor Activity/physiology , Parkinson Disease/physiopathology , Quality of Life , Aged , Analysis of Variance , Antiparkinson Agents/therapeutic use , Cross-Sectional Studies , Disability Evaluation , Dopamine Agonists/therapeutic use , Educational Status , Female , Humans , Levodopa/therapeutic use , Male , Middle Aged , Parkinson Disease/drug therapy , Reference Values , Statistics, Nonparametric , Surveys and Questionnaires
5.
BMJ Case Rep ; 20182018 Aug 27.
Article in English | MEDLINE | ID: mdl-30150329

ABSTRACT

A 37-year-old Hispanic man with a right atrial intracardiac mass diagnosed as diffuse large B-cell lymphoma (DLBCL) was successfully treated with surgery and chemotherapy. During 4 years, several total-body positron emission tomography and MRI scans showed no extracardiac lymphoma. On year 5 after the cardiac surgery, patient presented with sleepiness, hyperphagia, memory loss, confabulation, dementia and diabetes insipidus. Brain MRI showed a single hypothalamic recurrence of the original lymphoma that responded to high-dose methotrexate treatment. Correction of diabetes insipidus improved alertness but amnesia and cognitive deficits persisted, including incapacity to read and write. This case illustrates two unusual locations of DLBCL: primary cardiac lymphoma and hypothalamus. We emphasise the importance of third ventricle tumours as causing amnesia, confabulation, behavioural changes, alexia-agraphia, endocrine disorders and alterations of the circadian rhythm of wakefulness-sleep secondary to lesions of specific hypothalamic nuclei and disruption of hypothalamic-thalamic circuits.


Subject(s)
Antimetabolites, Antineoplastic/therapeutic use , Cerebral Ventricle Neoplasms/complications , Heart Neoplasms/therapy , Lymphoma, Large B-Cell, Diffuse/therapy , Methotrexate/therapeutic use , Neoplasm Recurrence, Local/diagnostic imaging , Third Ventricle/pathology , Adult , Cerebral Ventricle Neoplasms/diagnostic imaging , Cerebral Ventricle Neoplasms/physiopathology , Cerebral Ventricle Neoplasms/secondary , Diabetes Insipidus/etiology , Heart Neoplasms/diagnostic imaging , Heart Neoplasms/pathology , Humans , Hyperphagia/etiology , Lymphoma, Large B-Cell, Diffuse/diagnostic imaging , Lymphoma, Large B-Cell, Diffuse/pathology , Magnetic Resonance Imaging , Male , Memory Disorders/etiology , Neoplasm Recurrence, Local/physiopathology , Neoplasm Recurrence, Local/therapy , Positron Emission Tomography Computed Tomography , Third Ventricle/diagnostic imaging , Treatment Outcome
6.
Arq. neuropsiquiatr ; 76(8): 517-521, Aug. 2018. tab
Article in English | LILACS | ID: biblio-950571

ABSTRACT

ABSTRACT The wearing-off phenomenon is common in patients with Parkinson's disease. Motor and non-motor symptoms can fluctuate in relation to the "on/off" periods. Objective: To assess the impact of motor and non-motor wearing-off on activities of daily living and quality of life of patients with PD. Methods: A cross-sectional study was carried out. All patients were evaluated using the Movement Disorders Society Unified Parkinson's Disease Rating Scale. Wearing-off was assessed using the Wearing-Off Questionnaire-19, and quality of life was assessed using the Parkinson's Disease Questionnaire-8. Results: A total of 271 patients were included; 73.4% had wearing-off; 46.8% had both motor and non-motor fluctuations. Patients with both motor and non-motor wearing-off had a worst quality of life compared with those with only motor fluctuations (p = 0.047). Conclusions: Motor and non-motor fluctuations have an impact on activities of daily living and quality of life. Non-motor wearing-off may have a higher impact.


RESUMO O fenômeno de encurtamento do fim de dose é comum em pacientes com doença de Parkinson. Tanto os sintomas motores quanto os não motores podem flutuar em relação aos períodos de "on/off". Objetivo: Avaliar o impacto das flutuações motoras e não-motoras nas atividades da vida diária e qualidade de vida em pacientes com doença de Parkinson. Métodos: Um estudo transversal foi realizado. Todos os sujeitos foram avaliados utilizando a escala unificada para a doença de Parkinson da Sociedade de Distúrbios do Movimento. O encurtamento do fim de dose foi avaliado através do questionário WOQ-19 e a qualidade de vida foi avaliada através do PDQ-8. Resultados: Um total de 271 pacientes foram incluídos, 73,4% tiveram deterioração de fim de dose. A maioria dos pacientes tiveram tanto flutuações motoras quanto não-motoras (46,8%). Os pacientes com ambos os tipos de flutuações motoras e não-motoras tiveram pior qualidade de vida do que pacientes apenas com flutuações motoras (p = 0.047). Conclusões: Pacientes com flutuações motoras e não-motoras tiveram impacto significativo nas atividades da vida diária e na qualidade de vida. As flutuações não-motoras parecem ter um impacto maior que as flutuações motoras sobre a qualidade de vida.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Parkinson Disease/physiopathology , Quality of Life , Activities of Daily Living , Motor Activity/physiology , Parkinson Disease/drug therapy , Reference Values , Levodopa/therapeutic use , Cross-Sectional Studies , Surveys and Questionnaires , Analysis of Variance , Statistics, Nonparametric , Dopamine Agonists/therapeutic use , Disability Evaluation , Educational Status , Antiparkinson Agents/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...